Skip to main content
Log in

Diabetes mellitus contributes to carbamazepine resistance in patient with trigeminal neuralgia

  • Original Article
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Abstract

Objective

To determine whether diabetes mellitus (DM) contributes to the drug resistance of carbamazepine (CBZ), we investigated the correlation between the blood glucose status and the CBZ resistance condition in patients with trigeminal neuralgia (TN).

Patients and methods

A total of 155 TN patients treated with the CBZ monotherapy were selected at Shanghai General Hospital and Shanghai Xinhua Hospital from September 2018 to January 2020. Among them, 15 were diagnosed with DM. Patients’ CBZ resistance levels were evaluated according to progression-free survival. We utilized ordered multiple classification logistic regression to determine the dominant factors leading to CBZ resistance. We analyzed the correlation between hemoglobin A1c (HbA1c) and progression-free survival using the Pearson correlation analysis.

Results

The regression analysis showed that DM was the only factor affecting CBZ resistance (p = 0.035; OR = 0.327; 95% CI, 0.115–0.926). Progression-free survival was 28.5 ± 21.2 months in the DM group and 66.0 ± 33.2 months in the non-DM group. The concentration of HbA1c in the blood was negatively correlated with progression-free survival (r = − 0.197; p = 0.014).

Conclusions

This study shows that blood glucose status is a significant factor contributing to the CBZ resistance in the treatment of TN. The progression-free survival of patients is affected by the status of DM and blood HbAlc levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

Data is available upon reasonable request and with permission of Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine.

References

  1. Burke WJ, Grant JM, Selby G (1965) The treatment of trigeminal neuralgia: a clinical trial of carbamazepine ("TEGRETOL"). Med J Aust 1:494–498

    Article  CAS  Google Scholar 

  2. Collis JS Jr, Wallace TW (1968) Tic douloureux and diabetes mellitus. Cleve Clin Q 35:155–157. https://doi.org/10.3949/ccjm.35.3.155

    Article  PubMed  Google Scholar 

  3. Di Stefano G, La Cesa S, Truini A, Cruccu G (2014) Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J Headache Pain 15:34. https://doi.org/10.1186/1129-2377-15-34

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Goebel A, Moore A, Weatherall R, Roewer N, Schedel R, Sprotte G (2003) Intravenous immunoglobulin in the treatment of primary trigeminal neuralgia refractory to carbamazepine: a study protocol [ISRCTN33042138]. BMC Neurol 3:1–1. https://doi.org/10.1186/1471-2377-3-1

    Article  PubMed  PubMed Central  Google Scholar 

  5. Hagenacker T, Bude V, Naegel S, Holle D, Katsarava Z, Diener H-C, Obermann M (2014) Patient-conducted anodal transcranial direct current stimulation of the motor cortex alleviates pain in trigeminal neuralgia. J Headache Pain 15:78–78. https://doi.org/10.1186/1129-2377-15-78

    Article  PubMed  PubMed Central  Google Scholar 

  6. Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38:1–211. https://doi.org/10.1177/0333102417738202

    Article  Google Scholar 

  7. Hur YK, Choi IS, Cho JH, Park EJ, Choi JK, Choi BJ, Jang IS (2008) Effects of carbamazepine and amitriptyline on tetrodotoxinresistant Na+ channels in immature rat trigeminal ganglion neurons. Arch Pharm Res 31:178–182. https://doi.org/10.1007/s12272-001-1138-x

    Article  CAS  PubMed  Google Scholar 

  8. Jandova K, Pasler D, Antonio LL, Raue C, Ji S, Njunting M, Kann O, Kovacs R, Meencke HJ, Cavalheiro EA, Heinemann U, Gabriel S, Lehmann TN (2006) Carbamazepine-resistance in the epileptic dentate gyrus of human hippocampal slices. Brain 129:3290–3306. https://doi.org/10.1093/brain/awl218

    Article  PubMed  Google Scholar 

  9. Katusic S, Beard CM, Bergstralh E, Kurland LT (1990) Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol 27:89–95. https://doi.org/10.1002/ana.410270114

    Article  CAS  PubMed  Google Scholar 

  10. Killian JM, Fromm GH (1968) Carbamazepine in the treatment of neuralgia. Use of side effects. Arch Neurol 19:129–136

    Article  CAS  Google Scholar 

  11. Lechin F, van der Dijs B, Lechin ME, Amat J, Lechin AE, Cabrera A, Gómez F, Acosta E, Arocha L, Villa S (1989) Pimozide therapy for trigeminal neuralgia. Arch Neurol 46:960–963

    Article  CAS  Google Scholar 

  12. Lu ZH, Liu N, Bai R, Yao Y, Li SN, Yu RH, Sang CH, Tang RB, Long DY, Du X, Dong JZ, Ma CS (2015) HbA1c levels as predictors of ablation outcome in type 2 diabetes mellitus and paroxysmal atrial fibrillation. Herz 40(Suppl 2):130–136. https://doi.org/10.1007/s00059-014-4154-6

    Article  PubMed  Google Scholar 

  13. Maarbjerg S, Di Stefano G, Bendtsen L, Cruccu G (2017) Trigeminal neuralgia - diagnosis and treatment. Cephalalgia 37:648–657. https://doi.org/10.1177/0333102416687280

    Article  PubMed  Google Scholar 

  14. Marshall K, Chan MD, McCoy TP, Aubuchon AC, Bourland JD, McMullen KP, deGuzman AF, Munley MT, Shaw EG, Tatter SB, Ellis TL (2012) Predictive variables for the successful treatment of trigeminal neuralgia with gamma knife radiosurgery. Neurosurgery 70:566–572; discussion 572-563. https://doi.org/10.1227/NEU.0b013e3182320d36

    Article  PubMed  Google Scholar 

  15. Mueller D, Obermann M, Yoon MS, Poitz F, Hansen N, Slomke MA, Dommes P, Gizewski E, Diener HC, Katsarava Z (2011) Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: a population-based study. Cephalalgia 31:1542–1548. https://doi.org/10.1177/0333102411424619

    Article  PubMed  Google Scholar 

  16. Nurmikko TJ, Eldridge PR (2001) Trigeminal neuralgia--pathophysiology, diagnosis and current treatment. Br J Anaesth 87:117–132. https://doi.org/10.1093/bja/87.1.117

    Article  CAS  PubMed  Google Scholar 

  17. Rocamora R, Peltola J, Assenza G, McMurray R, Villanueva V (2019) Safety, tolerability and effectiveness of transition to eslicarbazepine acetate from carbamazepine or oxcarbazepine in clinical practice. Seizure 75:121–128. https://doi.org/10.1016/j.seizure.2019.12.022

    Article  PubMed  Google Scholar 

  18. Rockliff BW, Davis EH (1966) Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol 15:129–136. https://doi.org/10.1001/archneur.1966.00470140019003

    Article  CAS  PubMed  Google Scholar 

  19. Sanchez-Mejia RO, Limbo M, Cheng JS, Camara J, Ward MM, Barbaro NM (2005) Recurrent or refractory trigeminal neuralgia after microvascular decompression, radiofrequency ablation, or radiosurgery. Neurosurg Focus 18:e12

    Article  Google Scholar 

  20. Saudek CD, Derr RL, Kalyani RR (2006) Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. Jama 295:1688–1697. https://doi.org/10.1001/jama.295.14.1688

    Article  CAS  PubMed  Google Scholar 

  21. Shen M, Lim JME, Chia C, Ren EC (2020) CD39 regulatory T cells modulate the immune response to carbamazepine in HLA-B*15:02 carriers. Immunobiology 225:151868. https://doi.org/10.1016/j.imbio.2019.11.003

    Article  CAS  PubMed  Google Scholar 

  22. Shimazaki T, Kadowaki T, Ohyama Y, Ohe K, Kubota K (2007) Hemoglobin A1c (HbA1c) predicts future drug treatment for diabetes mellitus: a follow-up study using routine clinical data in a Japanese university hospital. Transl Res 149:196–204. https://doi.org/10.1016/j.trsl.2006.09.008

    Article  CAS  PubMed  Google Scholar 

  23. Sjaastad O, Bakketeig LS (2007) The rare, unilateral headaches. Vaga study of headache epidemiology. J Headache Pain 8:19–27. https://doi.org/10.1007/s10194-006-0292-4

    Article  PubMed  PubMed Central  Google Scholar 

  24. Takayama S, Osawa M, Takahashi Y, Iwamoto Y (2006) Painful neuropathy with trigeminal nerve involvement in type 2 diabetes. J Int Med Res 34:115–118. https://doi.org/10.1177/147323000603400115

    Article  CAS  PubMed  Google Scholar 

  25. Taylor JC, Brauer S, Espir ML (1981) Long-term treatment of trigeminal neuralgia with carbamazepine. Postgrad Med J 57:16–18. https://doi.org/10.1136/pgmj.57.663.16

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Tesfaye S (2011) Recent advances in the management of diabetic distal symmetrical polyneuropathy. J Diabetes Investig 2:33–42. https://doi.org/10.1111/j.2040-1124.2010.00083.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Wacker D, Wang C, Katritch V, Han GW, Huang XP, Vardy E, McCorvy JD, Jiang Y, Chu M, Siu FY, Liu W, Xu HE, Cherezov V, Roth BL, Stevens RC (2013) Structural features for functional selectivity at serotonin receptors. Science 340:615–619. https://doi.org/10.1126/science.1232808

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Wiffen PJ, Derry S, Moore RA, McQuay HJ (2011) Carbamazepine for acute and chronic pain in adults. Cochrane Database Syst Rev:Cd005451. https://doi.org/10.1002/14651858.CD005451.pub2

  29. Wiffen PJ, Derry S, Moore RA, Kalso EA (2014) Carbamazepine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev:Cd005451. https://doi.org/10.1002/14651858.CD005451.pub3

  30. Xu Z, Zhang P, Long L, He H, Zhang J, Sun S (2016) Diabetes mellitus in classical trigeminal neuralgia: a predisposing factor for its development. Clin Neurol Neurosurg 151:70–72. https://doi.org/10.1016/j.clineuro.2016.10.015

    Article  PubMed  Google Scholar 

  31. Yagihashi S, Mizukami H, Sugimoto K (2011) Mechanism of diabetic neuropathy: where are we now and where to go? J Diabetes Investig 2:18–32. https://doi.org/10.1111/j.2040-1124.2010.00070.x

    Article  CAS  PubMed  Google Scholar 

  32. Zakrzewska JM, Patsalos PN (2002) Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain 95:259–266

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors acknowledge the collaboration of all of the staff and technical member at Department of Neurosurgery, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Department of Neurosurgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; and Tongji University, Shanghai, China.

Funding

This research was funded by the National Natural Science Foundation of China (No. 81701359), the Natural Science Foundation of Shanghai (18ZR1430400), and the Cross Research Fund of Medicine and Engineering of Shanghai Jiaotong University (No. YG2016QN32, YG2019QNA67).

Author information

Authors and Affiliations

Authors

Contributions

Shaojian Lin conceived the original idea and Lili Wei developed the theoretical framework. All authors contributed to the interpretation of the results. All authors discussed the results and contributed to the final version of the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Lili Wei or Shaojian Lin.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Ethical approval and consent to participate

The study was conducted in accordance with local laws. Since it was a retrospective study, there was no need to sign an informed consent.

Consent for publication

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Anke Zhang, Wenbo Zhang, and Houshi Xu are co-first authors to the article

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, A., Zhang, W., Xu, H. et al. Diabetes mellitus contributes to carbamazepine resistance in patient with trigeminal neuralgia. Neurosurg Rev 44, 1119–1125 (2021). https://doi.org/10.1007/s10143-020-01304-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10143-020-01304-4

Keywords

Navigation